BlueDoor Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Buy
1,469
+42
+3% +$42.9K 0.74% 34
2026
Q1
$1.31M Buy
1,427
+25
+2% +$25.3K 0.61% 42
2025
Q4
$1.51M Buy
+1,402
New +$1.34M 0.7% 36

Other funds holding LLY

BlueDoor Private Wealth's LLY Position: Q2 2026 in Review

BlueDoor Private Wealth increased its Eli Lilly (LLY) stake by 2.9% in Q2 2026, buying an estimated $42.9K and bringing the position to 1,469 shares worth $1.76M. The position accounts for 0.74% of the portfolio, ranked #34.

BlueDoor Private Wealth first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BlueDoor Private Wealth held 1,469 shares of Eli Lilly worth $1.76M as of Q2 2026.
  • BlueDoor Private Wealth bought 42 Eli Lilly shares in Q2 2026, an estimated $42.9K.
  • Eli Lilly made up 0.74% of BlueDoor Private Wealth's portfolio in Q2 2026, its #34 holding.
  • BlueDoor Private Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BlueDoor Private Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.